Clarivate Report on U.S. Research Emphasizes Need for Continued International Collaboration and Domestic Regional Investment
Clarivate Plc (NYSE:CLVT) released a report highlighting the impact of globalization on U.S. research, urging for continued investment and collaboration to sustain its position as a science leader. The analysis, drawn from the Institute for Scientific Information, points out that U.S. research growth has not kept pace with global counterparts, particularly in Asia and the EU. Key findings include a doubling of international collaboration, particularly with Mainland China, and a decline in the diversity of research subjects due to faster budget increases in biomedicine. Furthermore, research output is unevenly distributed across the U.S., necessitating focused funding in weaker areas. The report warns that the U.S. no longer dominates global research, with other nations producing increasingly impactful papers.
- The U.S. remains an influential player in global research despite increasing competition.
- International collaboration in U.S. research has doubled for traditional partners and quadrupled with Mainland China.
- U.S. research growth has lagged compared to other global regions, particularly Asia and the EU.
- The diversity of research subjects is declining, with increased funding skewed towards biomedicine.
"
Key findings of the report include:
U.S. research investment, domestic research student numbers, and the output of research articles and reviews have not grown at the same rate as other parts of the world, resulting in increasing competition.- Most growth in
U.S. research publication output is attributable to international collaboration, which has doubled for major traditional partners such as theUnited Kingdom andGermany and quadrupled with Mainland China. - The physical sciences and technology areas are the subjects where the
U.S. has the greatest degree of international collaboration and the smallest component of purely domestic research output. MainlandChina is theU.S.'s most frequent partner in technology research and is as frequent as theU.K. andGermany in physical sciences. - The
U.S.'s research portfolio remains extensive and diverse, but its research subject diversity has declined due to the science budget expanding much faster in biomedicine than in technology areas. U.S research activity is unevenly spread across the country, but theU.S. has sought to address over-concentration of its innovation and development resources by structured funding directed to areas of relatively weak research capacity.- The
U.S. is strong but no longer dominates the research landscape as it did in the past. This is because other G7 nations are producing papers of the highest citation impact, while moreU.S. papers are now of world average citation impact.
Notes to editors:
Our Global Research Reports from the
https://clarivate.com/the-institute-for-scientific-information/isi-reports/
About Clarivate
Clarivate is a leading global information services provider. We connect people and organizations to intelligence they can trust to transform their perspective, their work and our world. Our subscription- and technology-based solutions are coupled with deep domain expertise and cover the areas of Academia & Government, Life Sciences & Healthcare and Intellectual Property. For more information, please visit clarivate.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/clarivate-report-on-us-research-emphasizes-need-for-continued-international-collaboration-and-domestic-regional-investment-301809381.html
SOURCE
FAQ
What does the Clarivate report say about U.S. research capacity?
How is U.S. research competition evolving according to the report?
What are the key findings related to international collaboration in U.S. research?
How has the trend of U.S. research output changed in recent years?